These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6193897)

  • 1. [Effect of biphenyl dicarboxylate on abnormal laboratory findings in patients with chronic hepatitis and liver cirrhosis].
    Yu HQ
    Zhong Xi Yi Jie He Za Zhi; 1983 May; 3(3):163-4. PubMed ID: 6193897
    [No Abstract]   [Full Text] [Related]  

  • 2. Yiqihuoxue and improvement of electrophoretic abnormalities of protein in chronic hepatitis and cirrhosis of liver.
    Yu HQ; Zhang YX; Chen GM; Wang XB
    J Tradit Chin Med; 1984 Mar; 4(1):39-44. PubMed ID: 6565883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution on the therapy of chronic liver parenchymal damage with 6-mercaptopurine].
    Mott R; Knief J; Faul J
    Med Klin; 1968 Sep; 63(36):1422-8. PubMed ID: 5729432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative evaluation of biochemical tests to determine the activity of the pathological process in patients with chronic hepatitis and cirrhosis of the liver who are receiving glucocorticoid therapy].
    Shul'man VSh; Tatarinova OM; Barenblat GZ
    Ter Arkh; 1969 Nov; 41(11):88-93. PubMed ID: 5384756
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum alpha fetoproteins (AFP) and immunologic reactivity in chronic liver diseases].
    Nicolaescu T; Bittman E; Bordeianu A; Boroş I; Gheorghe N; Stoiculescu P; Udrescu E; Pecec M; Stihi G; Voiculeţ N; Lenkei R
    Physiologie; 1979; 16(2):139-47. PubMed ID: 92795
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of pyrogenal on intracellular metabolism and phagocytic activity of leukocytes in patients with chronic liver diseases].
    Petrova TR; Ponomareva EP
    Klin Med (Mosk); 1975 Aug; 53(8):34-9. PubMed ID: 1186087
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum alpha-fetoprotein in nonneoplastic liver diseases.
    Chang FY; Wang WB; Chen TC
    Taiwan Yi Xue Hui Za Zhi; 1984 Aug; 83(8):765-72. PubMed ID: 6084045
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of progressive chronic hepatitis with intravenous administrations of colloidal iron].
    Fleischer J; Morgenstern D
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):29-30. PubMed ID: 5501422
    [No Abstract]   [Full Text] [Related]  

  • 9. The incidence of oxyphenisatin-induced liver damage in chronic non-alcoholic liver disease. A controlled investigation.
    Dietrichson O; Juhl E; Nielsen JO; Oxlund JJ; Christoffersen P
    Scand J Gastroenterol; 1974; 9(5):473-8. PubMed ID: 4605276
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of active chronic hepatitis with 6-mercaptopurine.
    Sjöberg KH; Welin G
    Acta Hepatosplenol; 1967; 14(3):157-62. PubMed ID: 4172443
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-fetoprotein in patients with primary liver cancer and other liver diseases.
    Zuberi SJ; Lodi TZ; Nazli A
    J Pak Med Assoc; 1977 Jun; 27(6):348-50. PubMed ID: 74425
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic significance of alpha-fetoproteins in hepatic pathology].
    Mebazaa A; Ben Naceur M; Rachdi MT; Garoui H; Gargouri M
    Tunis Med; 1985 Mar; 63(3):237-40. PubMed ID: 2411038
    [No Abstract]   [Full Text] [Related]  

  • 13. The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease.
    Chen CY; Tsai WL; Lin PJ; Shiesh SC
    Clin Chem Lab Med; 2011 Nov; 49(11):1817-21. PubMed ID: 21851314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood coagulation activity in patients with chronic hepatitis and cirrhosis of the liver, treated with glucocorticoid hormones].
    Zlatkina AR; Levantovskaia OM; Kravtsova EF
    Ter Arkh; 1972 Apr; 44(4):98-102. PubMed ID: 5051568
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha-fetoprotein and hepatitis B virus infection in chronic liver disease.
    Solinas A; Madeddu G; Tocco A; Deplano A; Diana MS; Pirisi M; Marras G; Casu AR; Dore F; Langer M
    J Nucl Med Allied Sci; 1987; 31(2):183-8. PubMed ID: 2442327
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prednisolone therapy of patients with chronic hepatitis and cirrhosis of the liver].
    Vasil'eva LN
    Klin Med (Mosk); 1966 May; 44(5):42-8. PubMed ID: 5990929
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of chronic liver diseases with prednisolone and alpha-lipoic acid].
    Loginow AS
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):19-23. PubMed ID: 4925665
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of liver hydrolysates and corticosteroids in chronic hepatitis and liver cirrhosis].
    Bakulenko EF
    Vrach Delo; 1976 Apr; (4):108-10. PubMed ID: 1007172
    [No Abstract]   [Full Text] [Related]  

  • 19. Control of endotoxinemia in liver disease by lactulose and paromomycin.
    Scevola D; Magliulo E; Trpin L; Benzi-Cipelli R; Bernardi R
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):242-7. PubMed ID: 518757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of the use of immunosuppressive agents in the treatment of chronic hepatitis and liver cirrhosis].
    Vakulenko EF
    Vrach Delo; 1975 Sep; (9):55-6. PubMed ID: 1210301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.